International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature, 2004; 431:931–945.
2.
HubéF, FrancastelC. Mammalian introns: When the junk generates molecular diversity. Int J Mol Sci, 2015; 16:4429–4452.
3.
BrookesAJ. The essence of SNPs. Gene, 1999; 234:177–186.
4.
MullaneyJM, MillsRE, PittardWS, DevineSE. Small insertions and deletions (INDELs) in human genomes. Hum Mol Genet, 2010; 19(R2):R131–R136.
5.
OuahchiK, LindemanN, LeeC. Copy number variants and pharmacogenomics. Pharmacogenomics, 2006; 7:25–29.
6.
WangLS, TangJJ, TangNP, et al.Association of GSTM1 and GSTT1 gene polymorphisms with coronary artery disease in relation to tobacco smoking. Clin Chem Lab Med, 2008; 46:1720–1725.
7.
LiQ, ZhangY, JiaL, PengX. A novel nonsense mutation in BBS4 gene identified in a Chinese family with Bardet-Biedl syndrome. Chin Med J (Engl), 2014; 127:4190–4196.
8.
ZengP, ZhaoY, QianC, et al.Statistical analysis for genome-wide association study. J Biomed Res, 2015; 29:285–297.
9.
CrewsKR, GaedigkA, DunnenbergerHM, et al.; Clinical Pharmacogenetics Implementation Consortium. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin Pharmacol Ther, 2014; 95:376–382.
10.
SmithEC. Understanding CYP2D6 and its role in tamoxifen metabolism. Oncol Nurs Forum, 2013; 40:547–548.
11.
BinkhorstL, MathijssenRH, JagerA, van GelderT. Individualization of tamoxifen therapy: Much more than just CYP2D6 genotyping. Cancer Treat Rev, 2015; 41:289–299.
12.
de LeonJ, SusceMT, Murray-CarmichaelE. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool. Mol Diagn Ther, 2006; 10:135–151.
13.
BreilingA, LykoF. Epigenetic regulatory functions of DNA modifications: 5-methylcytosine and beyond. Epigenetics Chromatin, 2015; 8:2–4.
14.
KeatingST, El-OstaA. Epigenetics and metabolism. Circ Res, 2015; 116:715–736.
15.
WaterlandRA, JirtleRL. Transposable elements: Targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol, 2003; 23:5293–5300.
16.
DolinoyDC, HuangD, JirtleRL. Maternal nutrient supplementation counteracts bisphenol A–induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A, 2007; 104:13056–13061.
17.
SubbiahMT. Nutrigenetics and nutraceuticals: The next wave riding on personalized medicine. Transl Res, 2007; 149:55–61.
18.
BurrellRA, SwantonC. Tumour heterogeneity and the evolution of polyclonal drug resistance. Mol Oncol, 2014; 8:1095–1111.
19.
JiangT, ZhouC. The past, present and future of immunotherapy against tumor. Transl Lung Cancer Res, 2015; 4:253–264.
